51³Ô¹ÏÍø

Pembrolizumab immunotherapy drug, illustration - stock illustration

Illustration of pembrolizumab (marketed under the name Keytruda), a drug that treats various types of cancers. Pembrolizumab is a therapeutic antibody that binds to and blocks programmed cell death protein 1 (PD-1) located on lymphocyte white blood cells
Illustration of pembrolizumab (marketed under the name Keytruda), a drug that treats various types of cancers. Pembrolizumab is a therapeutic antibody that binds to and blocks programmed cell death protein 1 (PD-1) located on lymphocyte white blood cells
Pembrolizumab immunotherapy drug, illustration
Get this image in a variety of framing options at Photos.com.
PURCHASE A LICENSE
All Royalty-Free licenses include global use rights, comprehensive protection, simple pricing with volume discounts available
€300.00
EUR
Getty ImagesPembrolizumab Immunotherapy Drug Illustration High-Res Vector GraphicPembrolizumab Immunotherapy Drug Illustration High-Res Vector GraphicDownload premium, authentic Pembrolizumab immunotherapy drug, illustration stock illustrations from 51³Ô¹ÏÍø Explore similar high-resolution stock illustrations in our expansive visual catalogue.Product #:2172899565
€300€40
Getty Images
In stock

DETAILS

Credit:
BEHNOUSH HAJIAN/SCIENCE PHOTO LIBRARY
51³Ô¹ÏÍø #:
2172899565
License type:
Royalty-free
Collection:
Science Photo Library
Max file size:
5590 x 3144 px (18.63 x 10.48 in) - 300 dpi - 8 MB
Upload date:
Release info:
No release required
Categories: